These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14521196)

  • 1. Why have drug treatments been so disappointing?
    Buitelaar JK
    Novartis Found Symp; 2003; 251():235-44; discussion 245-9, 281-97. PubMed ID: 14521196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological interventions in autism: theoretical and practical issues.
    Volkmar FR
    J Clin Child Psychol; 2001 Mar; 30(1):80-7. PubMed ID: 11294081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic treatment for the core deficits and associated symptoms of autism in children.
    West L; Waldrop J; Brunssen S
    J Pediatr Health Care; 2009; 23(2):75-89. PubMed ID: 19232924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on pharmacologic treatments for autism spectrum disorders.
    King BH; Bostic JQ
    Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):161-75. PubMed ID: 16321729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.
    Findling RL
    J Clin Psychiatry; 2005; 66 Suppl 10():26-31. PubMed ID: 16401147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autism spectrum disorders: sex differences in autistic behaviour domains and coexisting psychopathology.
    Holtmann M; Bölte S; Poustka F
    Dev Med Child Neurol; 2007 May; 49(5):361-6. PubMed ID: 17489810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemistry in the pathophysiology of autism.
    McDougle CJ; Erickson CA; Stigler KA; Posey DJ
    J Clin Psychiatry; 2005; 66 Suppl 10():9-18. PubMed ID: 16401145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit].
    Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O
    Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foundations for self and other: a study in autism.
    Hobson RP; Meyer JA
    Dev Sci; 2005 Nov; 8(6):481-91. PubMed ID: 16246239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of atypical antipsychotics in the treatment of autistic disorder.
    Stachnik JM; Nunn-Thompson C
    Ann Pharmacother; 2007 Apr; 41(4):626-34. PubMed ID: 17389666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for the administration of opiate antagonists in treating infantile autism.
    Deutsch SI
    Am J Ment Defic; 1986 May; 90(6):631-5. PubMed ID: 2872816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging drugs in Tourette syndrome.
    Silay YS; Jankovic J
    Expert Opin Emerg Drugs; 2005 May; 10(2):365-80. PubMed ID: 15934872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social and communication behaviours in infants and toddlers with autism and pervasive developmental disorder-not otherwise specified.
    Fodstad JC; Matson JL; Hess J; Neal D
    Dev Neurorehabil; 2009 Jun; 12(3):152-7. PubMed ID: 19466623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The simulating social mind: the role of the mirror neuron system and simulation in the social and communicative deficits of autism spectrum disorders.
    Oberman LM; Ramachandran VS
    Psychol Bull; 2007 Mar; 133(2):310-27. PubMed ID: 17338602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AEDs and psychotropic drugs in children with autism and epilepsy.
    Tuchman R
    Ment Retard Dev Disabil Res Rev; 2004; 10(2):135-8. PubMed ID: 15362171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.